aluates Reports

$ 0.0

Automative

Global Tumor-Specific Antigen Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-38D105

Global Tumor Specific Antigen Market Insights Forecast to 2028

BUY CHAPTERS

Global Tumor-Specific Antigen Market Insights, Forecast to 2030

Code: QYRE-Auto-38D105

Report

December 2024

Pages:109

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Agilent Technologies

Creative Diagnostics

Go Therapeutics

Lee Biosolutions

Bio Rad

bioMrieux

Caris Life Sciences

Roche

Abcam

Merck Group

PerkinElmer Inc

Origene Technologies

Tumor-Specific Antigen Market Size

The global Tumor-Specific Antigen market is projected to grow from US$ 2273.2 million in 2024 to US$ 3121.9 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.4% during the forecast period.

Tumor-Specific Antigen Market

Tumor-specific Antigen is a new Antigen that is expressed on the surface of certain Tumor cells but not on normal cells.Such antigens may be present in tumors of the same tissue type in different individuals.Tumor-specific antigens help the body develop an immune response to cancer cells.They could be used as potential targets for targeted therapy or immunotherapy to help improve the body's immune system to kill more cancer cells.Tumor-specific antigens can also be used in laboratory tests to help identify certain types of cancer.

Market Analysis and Insights: Global Tumor-Specific Antigen Market

The US & Canada market for Tumor-Specific Antigen is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Tumor-Specific Antigen is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Tumor-Specific Antigen is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of Tumor-Specific Antigen include Agilent Technologies, Creative Diagnostics, Go Therapeutics, Lee Biosolutions, Bio-Rad, Biomrieux, Caris Life Sciences, Roche and Abcam, etc. In 2023, the global top five players had a share approximately % in terms of revenue.

Tumor-Specific Antigen is widely used in various fields, such as Drug Discovery and Development, Diagnostics, Clinical and Basic Research and Others, etc. Drug Discovery and Development provides greatest supports to the Tumor-Specific Antigen industry development. In 2023, global % revenue of Tumor-Specific Antigen went into Drug Discovery and Development filed and the proportion will reach to % in 2030.

Report Covers:

This report presents an overview of global market for Tumor-Specific Antigen market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Tumor-Specific Antigen, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Tumor-Specific Antigen, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Tumor-Specific Antigen revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Tumor-Specific Antigen market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Tumor-Specific Antigen revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Tumor-Specific Antigen Market Report

Report Metric	Details
Report Name	Tumor-Specific Antigen Market
Accounted market size in 2024	US$ 2273.2 million
Forecasted market size in 2030	US$ 3121.9 million
CAGR	5.4
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Coding Region Non-Coding Region
Segment by Application	Drug Discovery and Development Diagnostics Clinical and Basic Research Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Agilent Technologies, Creative Diagnostics, Go Therapeutics, Lee Biosolutions, Bio-Rad, Biomrieux, Caris Life Sciences, Roche, Abcam, Merck Group, PerkinElmer, OriGene Technologies
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Tumor-Specific Antigen in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tumor-Specific Antigen companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tumor-Specific Antigen revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Tumor-Specific Antigen Market growing?

Ans: The Tumor-Specific Antigen Market witnessing a CAGR of 5.4 during the forecast period 2025-2030.

What is the Tumor-Specific Antigen Market size in 2030?

Ans: The Tumor-Specific Antigen Market size in 2030 will be US$ 3121.9 million.

Who are the main players in the Tumor-Specific Antigen Market report?

Ans: The main players in the Tumor-Specific Antigen Market are Agilent Technologies, Creative Diagnostics, Go Therapeutics, Lee Biosolutions, Bio-Rad, Biomrieux, Caris Life Sciences, Roche, Abcam, Merck Group, PerkinElmer, OriGene Technologies

What are the Application segmentation covered in the Tumor-Specific Antigen Market report?

Ans: The Applications covered in the Tumor-Specific Antigen Market report are Drug Discovery and Development, Diagnostics, Clinical and Basic Research, Others

What are the Type segmentation covered in the Tumor-Specific Antigen Market report?

Ans: The Types covered in the Tumor-Specific Antigen Market report are Coding Region, Non-Coding Region

Recommended Reports

Tumor Antigen Diagnostics

Cancer Immunotherapy

Oncology Drug Development

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Tumor-Specific Antigen Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Coding Region

1.2.3 Non-Coding Region

1.3 Market by Application

1.3.1 Global Tumor-Specific Antigen Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Drug Discovery and Development

1.3.3 Diagnostics

1.3.4 Clinical and Basic Research

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Tumor-Specific Antigen Market Perspective (2019-2030)

2.2 Global Tumor-Specific Antigen Growth Trends by Region

2.2.1 Tumor-Specific Antigen Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Tumor-Specific Antigen Historic Market Size by Region (2019-2024)

2.2.3 Tumor-Specific Antigen Forecasted Market Size by Region (2025-2030)

2.3 Tumor-Specific Antigen Market Dynamics

2.3.1 Tumor-Specific Antigen Industry Trends

2.3.2 Tumor-Specific Antigen Market Drivers

2.3.3 Tumor-Specific Antigen Market Challenges

2.3.4 Tumor-Specific Antigen Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Tumor-Specific Antigen by Players

3.1.1 Global Tumor-Specific Antigen Revenue by Players (2019-2024)

3.1.2 Global Tumor-Specific Antigen Revenue Market Share by Players (2019-2024)

3.2 Global Tumor-Specific Antigen Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Tumor-Specific Antigen, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Tumor-Specific Antigen Market Concentration Ratio

3.4.1 Global Tumor-Specific Antigen Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Tumor-Specific Antigen Revenue in 2023

3.5 Global Key Players of Tumor-Specific Antigen Head office and Area Served

3.6 Global Key Players of Tumor-Specific Antigen, Product and Application

3.7 Global Key Players of Tumor-Specific Antigen, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Tumor-Specific Antigen Breakdown Data by Type

4.1 Global Tumor-Specific Antigen Historic Market Size by Type (2019-2024)

4.2 Global Tumor-Specific Antigen Forecasted Market Size by Type (2025-2030)

5 Tumor-Specific Antigen Breakdown Data by Application

5.1 Global Tumor-Specific Antigen Historic Market Size by Application (2019-2024)

5.2 Global Tumor-Specific Antigen Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Tumor-Specific Antigen Market Size (2019-2030)

6.2 North America Tumor-Specific Antigen Market Size by Type

6.2.1 North America Tumor-Specific Antigen Market Size by Type (2019-2024)

6.2.2 North America Tumor-Specific Antigen Market Size by Type (2025-2030)

6.2.3 North America Tumor-Specific Antigen Market Share by Type (2019-2030)

6.3 North America Tumor-Specific Antigen Market Size by Application

6.3.1 North America Tumor-Specific Antigen Market Size by Application (2019-2024)

6.3.2 North America Tumor-Specific Antigen Market Size by Application (2025-2030)

6.3.3 North America Tumor-Specific Antigen Market Share by Application (2019-2030)

6.4 North America Tumor-Specific Antigen Market Size by Country

6.4.1 North America Tumor-Specific Antigen Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Tumor-Specific Antigen Market Size by Country (2019-2024)

6.4.3 North America Tumor-Specific Antigen Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Tumor-Specific Antigen Market Size (2019-2030)

7.2 Europe Tumor-Specific Antigen Market Size by Type

7.2.1 Europe Tumor-Specific Antigen Market Size by Type (2019-2024)

7.2.2 Europe Tumor-Specific Antigen Market Size by Type (2025-2030)

7.2.3 Europe Tumor-Specific Antigen Market Share by Type (2019-2030)

7.3 Europe Tumor-Specific Antigen Market Size by Application

7.3.1 Europe Tumor-Specific Antigen Market Size by Application (2019-2024)

7.3.2 Europe Tumor-Specific Antigen Market Size by Application (2025-2030)

7.3.3 Europe Tumor-Specific Antigen Market Share by Application (2019-2030)

7.4 Europe Tumor-Specific Antigen Market Size by Country

7.4.1 Europe Tumor-Specific Antigen Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Tumor-Specific Antigen Market Size by Country (2019-2024)

7.4.3 Europe Tumor-Specific Antigen Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Tumor-Specific Antigen Market Size (2019-2030)

8.2 China Tumor-Specific Antigen Market Size by Type

8.2.1 China Tumor-Specific Antigen Market Size by Type (2019-2024)

8.2.2 China Tumor-Specific Antigen Market Size by Type (2025-2030)

8.2.3 China Tumor-Specific Antigen Market Share by Type (2019-2030)

8.3 China Tumor-Specific Antigen Market Size by Application

8.3.1 China Tumor-Specific Antigen Market Size by Application (2019-2024)

8.3.2 China Tumor-Specific Antigen Market Size by Application (2025-2030)

8.3.3 China Tumor-Specific Antigen Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Tumor-Specific Antigen Market Size (2019-2030)

9.2 Asia Tumor-Specific Antigen Market Size by Type

9.2.1 Asia Tumor-Specific Antigen Market Size by Type (2019-2024)

9.2.2 Asia Tumor-Specific Antigen Market Size by Type (2025-2030)

9.2.3 Asia Tumor-Specific Antigen Market Share by Type (2019-2030)

9.3 Asia Tumor-Specific Antigen Market Size by Application

9.3.1 Asia Tumor-Specific Antigen Market Size by Application (2019-2024)

9.3.2 Asia Tumor-Specific Antigen Market Size by Application (2025-2030)

9.3.3 Asia Tumor-Specific Antigen Market Share by Application (2019-2030)

9.4 Asia Tumor-Specific Antigen Market Size by Region

9.4.1 Asia Tumor-Specific Antigen Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Tumor-Specific Antigen Market Size by Region (2019-2024)

9.4.3 Asia Tumor-Specific Antigen Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Tumor-Specific Antigen Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Tumor-Specific Antigen Market Size by Type

10.2.1 Middle East, Africa, and Latin America Tumor-Specific Antigen Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Tumor-Specific Antigen Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Tumor-Specific Antigen Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Tumor-Specific Antigen Market Size by Application

10.3.1 Middle East, Africa, and Latin America Tumor-Specific Antigen Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Tumor-Specific Antigen Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Tumor-Specific Antigen Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Tumor-Specific Antigen Market Size by Country

10.4.1 Middle East, Africa, and Latin America Tumor-Specific Antigen Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Tumor-Specific Antigen Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Tumor-Specific Antigen Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Agilent Technologies

11.1.1 Agilent Technologies Company Details

11.1.2 Agilent Technologies Business Overview

11.1.3 Agilent Technologies Tumor-Specific Antigen Introduction

11.1.4 Agilent Technologies Revenue in Tumor-Specific Antigen Business (2019-2024)

11.1.5 Agilent Technologies Recent Developments

11.2 Creative Diagnostics

11.2.1 Creative Diagnostics Company Details

11.2.2 Creative Diagnostics Business Overview

11.2.3 Creative Diagnostics Tumor-Specific Antigen Introduction

11.2.4 Creative Diagnostics Revenue in Tumor-Specific Antigen Business (2019-2024)

11.2.5 Creative Diagnostics Recent Developments

11.3 Go Therapeutics

11.3.1 Go Therapeutics Company Details

11.3.2 Go Therapeutics Business Overview

11.3.3 Go Therapeutics Tumor-Specific Antigen Introduction

11.3.4 Go Therapeutics Revenue in Tumor-Specific Antigen Business (2019-2024)

11.3.5 Go Therapeutics Recent Developments

11.4 Lee Biosolutions

11.4.1 Lee Biosolutions Company Details

11.4.2 Lee Biosolutions Business Overview

11.4.3 Lee Biosolutions Tumor-Specific Antigen Introduction

11.4.4 Lee Biosolutions Revenue in Tumor-Specific Antigen Business (2019-2024)

11.4.5 Lee Biosolutions Recent Developments

11.5 Bio-Rad

11.5.1 Bio-Rad Company Details

11.5.2 Bio-Rad Business Overview

11.5.3 Bio-Rad Tumor-Specific Antigen Introduction

11.5.4 Bio-Rad Revenue in Tumor-Specific Antigen Business (2019-2024)

11.5.5 Bio-Rad Recent Developments

11.6 Biomrieux

11.6.1 Biomrieux Company Details

11.6.2 Biomrieux Business Overview

11.6.3 Biomrieux Tumor-Specific Antigen Introduction

11.6.4 Biomrieux Revenue in Tumor-Specific Antigen Business (2019-2024)

11.6.5 Biomrieux Recent Developments

11.7 Caris Life Sciences

11.7.1 Caris Life Sciences Company Details

11.7.2 Caris Life Sciences Business Overview

11.7.3 Caris Life Sciences Tumor-Specific Antigen Introduction

11.7.4 Caris Life Sciences Revenue in Tumor-Specific Antigen Business (2019-2024)

11.7.5 Caris Life Sciences Recent Developments

11.8 Roche

11.8.1 Roche Company Details

11.8.2 Roche Business Overview

11.8.3 Roche Tumor-Specific Antigen Introduction

11.8.4 Roche Revenue in Tumor-Specific Antigen Business (2019-2024)

11.8.5 Roche Recent Developments

11.9 Abcam

11.9.1 Abcam Company Details

11.9.2 Abcam Business Overview

11.9.3 Abcam Tumor-Specific Antigen Introduction

11.9.4 Abcam Revenue in Tumor-Specific Antigen Business (2019-2024)

11.9.5 Abcam Recent Developments

11.10 Merck Group

11.10.1 Merck Group Company Details

11.10.2 Merck Group Business Overview

11.10.3 Merck Group Tumor-Specific Antigen Introduction

11.10.4 Merck Group Revenue in Tumor-Specific Antigen Business (2019-2024)

11.10.5 Merck Group Recent Developments

11.11 PerkinElmer

11.11.1 PerkinElmer Company Details

11.11.2 PerkinElmer Business Overview

11.11.3 PerkinElmer Tumor-Specific Antigen Introduction

11.11.4 PerkinElmer Revenue in Tumor-Specific Antigen Business (2019-2024)

11.11.5 PerkinElmer Recent Developments

11.12 OriGene Technologies

11.12.1 OriGene Technologies Company Details

11.12.2 OriGene Technologies Business Overview

11.12.3 OriGene Technologies Tumor-Specific Antigen Introduction

11.12.4 OriGene Technologies Revenue in Tumor-Specific Antigen Business (2019-2024)

11.12.5 OriGene Technologies Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Agilent Technologies

Creative Diagnostics

Go Therapeutics

Lee Biosolutions

Bio Rad

bioMrieux

Caris Life Sciences

Roche

Abcam

Merck Group

PerkinElmer Inc

Origene Technologies

List of Tables

Table 1. Global Tumor-Specific Antigen Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Coding Region

Table 3. Key Players of Non-Coding Region

Table 4. Global Tumor-Specific Antigen Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 5. Global Tumor-Specific Antigen Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Tumor-Specific Antigen Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Tumor-Specific Antigen Market Share by Region (2019-2024)

Table 8. Global Tumor-Specific Antigen Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Tumor-Specific Antigen Market Share by Region (2025-2030)

Table 10. Tumor-Specific Antigen Market Trends

Table 11. Tumor-Specific Antigen Market Drivers

Table 12. Tumor-Specific Antigen Market Challenges

Table 13. Tumor-Specific Antigen Market Restraints

Table 14. Global Tumor-Specific Antigen Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Tumor-Specific Antigen Revenue Share by Players (2019-2024)

Table 16. Global Top Tumor-Specific Antigen by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor-Specific Antigen as of 2023)

Table 17. Global Tumor-Specific Antigen Industry Ranking 2022 VS 2023 VS 2024

Table 18. Global 5 Largest Players Market Share by Tumor-Specific Antigen Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of Tumor-Specific Antigen, Headquarters and Area Served

Table 20. Global Key Players of Tumor-Specific Antigen, Product and Application

Table 21. Global Key Players of Tumor-Specific Antigen, Product and Application

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Tumor-Specific Antigen Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Tumor-Specific Antigen Revenue Market Share by Type (2019-2024)

Table 25. Global Tumor-Specific Antigen Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Tumor-Specific Antigen Revenue Market Share by Type (2025-2030)

Table 27. Global Tumor-Specific Antigen Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Tumor-Specific Antigen Revenue Share by Application (2019-2024)

Table 29. Global Tumor-Specific Antigen Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Tumor-Specific Antigen Revenue Share by Application (2025-2030)

Table 31. North America Tumor-Specific Antigen Market Size by Type (2019-2024) & (US$ Million)

Table 32. North America Tumor-Specific Antigen Market Size by Type (2025-2030) & (US$ Million)

Table 33. North America Tumor-Specific Antigen Market Size by Application (2019-2024) & (US$ Million)

Table 34. North America Tumor-Specific Antigen Market Size by Application (2025-2030) & (US$ Million)

Table 35. North America Tumor-Specific Antigen Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Tumor-Specific Antigen Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Tumor-Specific Antigen Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Tumor-Specific Antigen Market Size by Type (2019-2024) & (US$ Million)

Table 39. Europe Tumor-Specific Antigen Market Size by Type (2025-2030) & (US$ Million)

Table 40. Europe Tumor-Specific Antigen Market Size by Application (2019-2024) & (US$ Million)

Table 41. Europe Tumor-Specific Antigen Market Size by Application (2025-2030) & (US$ Million)

Table 42. Europe Tumor-Specific Antigen Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Europe Tumor-Specific Antigen Market Size by Country (2019-2024) & (US$ Million)

Table 44. Europe Tumor-Specific Antigen Market Size by Country (2025-2030) & (US$ Million)

Table 45. China Tumor-Specific Antigen Market Size by Type (2019-2024) & (US$ Million)

Table 46. China Tumor-Specific Antigen Market Size by Type (2025-2030) & (US$ Million)

Table 47. China Tumor-Specific Antigen Market Size by Application (2019-2024) & (US$ Million)

Table 48. China Tumor-Specific Antigen Market Size by Application (2025-2030) & (US$ Million)

Table 49. Asia Tumor-Specific Antigen Market Size by Type (2019-2024) & (US$ Million)

Table 50. Asia Tumor-Specific Antigen Market Size by Type (2025-2030) & (US$ Million)

Table 51. Asia Tumor-Specific Antigen Market Size by Application (2019-2024) & (US$ Million)

Table 52. Asia Tumor-Specific Antigen Market Size by Application (2025-2030) & (US$ Million)

Table 53. Asia Tumor-Specific Antigen Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 54. Asia Tumor-Specific Antigen Market Size by Region (2019-2024) & (US$ Million)

Table 55. Asia Tumor-Specific Antigen Market Size by Region (2025-2030) & (US$ Million)

Table 56. Middle East, Africa, and Latin America Tumor-Specific Antigen Market Size by Type (2019-2024) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Tumor-Specific Antigen Market Size by Type (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Tumor-Specific Antigen Market Size by Application (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Tumor-Specific Antigen Market Size by Application (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Tumor-Specific Antigen Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 61. Middle East, Africa, and Latin America Tumor-Specific Antigen Market Size by Country (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Tumor-Specific Antigen Market Size by Country (2025-2030) & (US$ Million)

Table 63. Agilent Technologies Company Details

Table 64. Agilent Technologies Business Overview

Table 65. Agilent Technologies Tumor-Specific Antigen Product

Table 66. Agilent Technologies Revenue in Tumor-Specific Antigen Business (2019-2024) & (US$ Million)

Table 67. Agilent Technologies Recent Developments

Table 68. Creative Diagnostics Company Details

Table 69. Creative Diagnostics Business Overview

Table 70. Creative Diagnostics Tumor-Specific Antigen Product

Table 71. Creative Diagnostics Revenue in Tumor-Specific Antigen Business (2019-2024) & (US$ Million)

Table 72. Creative Diagnostics Recent Developments

Table 73. Go Therapeutics Company Details

Table 74. Go Therapeutics Business Overview

Table 75. Go Therapeutics Tumor-Specific Antigen Product

Table 76. Go Therapeutics Revenue in Tumor-Specific Antigen Business (2019-2024) & (US$ Million)

Table 77. Go Therapeutics Recent Developments

Table 78. Lee Biosolutions Company Details

Table 79. Lee Biosolutions Business Overview

Table 80. Lee Biosolutions Tumor-Specific Antigen Product

Table 81. Lee Biosolutions Revenue in Tumor-Specific Antigen Business (2019-2024) & (US$ Million)

Table 82. Lee Biosolutions Recent Developments

Table 83. Bio-Rad Company Details

Table 84. Bio-Rad Business Overview

Table 85. Bio-Rad Tumor-Specific Antigen Product

Table 86. Bio-Rad Revenue in Tumor-Specific Antigen Business (2019-2024) & (US$ Million)

Table 87. Bio-Rad Recent Developments

Table 88. Biomrieux Company Details

Table 89. Biomrieux Business Overview

Table 90. Biomrieux Tumor-Specific Antigen Product

Table 91. Biomrieux Revenue in Tumor-Specific Antigen Business (2019-2024) & (US$ Million)

Table 92. Biomrieux Recent Developments

Table 93. Caris Life Sciences Company Details

Table 94. Caris Life Sciences Business Overview

Table 95. Caris Life Sciences Tumor-Specific Antigen Product

Table 96. Caris Life Sciences Revenue in Tumor-Specific Antigen Business (2019-2024) & (US$ Million)

Table 97. Caris Life Sciences Recent Developments

Table 98. Roche Company Details

Table 99. Roche Business Overview

Table 100. Roche Tumor-Specific Antigen Product

Table 101. Roche Revenue in Tumor-Specific Antigen Business (2019-2024) & (US$ Million)

Table 102. Roche Recent Developments

Table 103. Abcam Company Details

Table 104. Abcam Business Overview

Table 105. Abcam Tumor-Specific Antigen Product

Table 106. Abcam Revenue in Tumor-Specific Antigen Business (2019-2024) & (US$ Million)

Table 107. Abcam Recent Developments

Table 108. Merck Group Company Details

Table 109. Merck Group Business Overview

Table 110. Merck Group Tumor-Specific Antigen Product

Table 111. Merck Group Revenue in Tumor-Specific Antigen Business (2019-2024) & (US$ Million)

Table 112. Merck Group Recent Developments

Table 113. PerkinElmer Company Details

Table 114. PerkinElmer Business Overview

Table 115. PerkinElmer Tumor-Specific Antigen Product

Table 116. PerkinElmer Revenue in Tumor-Specific Antigen Business (2019-2024) & (US$ Million)

Table 117. PerkinElmer Recent Developments

Table 118. OriGene Technologies Company Details

Table 119. OriGene Technologies Business Overview

Table 120. OriGene Technologies Tumor-Specific Antigen Product

Table 121. OriGene Technologies Revenue in Tumor-Specific Antigen Business (2019-2024) & (US$ Million)

Table 122. OriGene Technologies Recent Developments

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Tumor-Specific Antigen Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Tumor-Specific Antigen Market Share by Type: 2023 VS 2030

Figure 3. Coding Region Features

Figure 4. Non-Coding Region Features

Figure 5. Global Tumor-Specific Antigen Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 6. Global Tumor-Specific Antigen Market Share by Application: 2023 VS 2030

Figure 7. Drug Discovery and Development Case Studies

Figure 8. Diagnostics Case Studies

Figure 9. Clinical and Basic Research Case Studies

Figure 10. Others Case Studies

Figure 11. Tumor-Specific Antigen Report Years Considered

Figure 12. Global Tumor-Specific Antigen Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Tumor-Specific Antigen Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Tumor-Specific Antigen Market Share by Region: 2023 VS 2030

Figure 15. Global Tumor-Specific Antigen Market Share by Players in 2023

Figure 16. Global Top Tumor-Specific Antigen Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor-Specific Antigen as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Tumor-Specific Antigen Revenue in 2023

Figure 18. North America Tumor-Specific Antigen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Tumor-Specific Antigen Market Share by Type (2019-2030)

Figure 20. North America Tumor-Specific Antigen Market Share by Application (2019-2030)

Figure 21. North America Tumor-Specific Antigen Market Share by Country (2019-2030)

Figure 22. United States Tumor-Specific Antigen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Tumor-Specific Antigen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Tumor-Specific Antigen Market Size YoY (2019-2030) & (US$ Million)

Figure 25. Europe Tumor-Specific Antigen Market Share by Type (2019-2030)

Figure 26. Europe Tumor-Specific Antigen Market Share by Application (2019-2030)

Figure 27. Europe Tumor-Specific Antigen Market Share by Country (2019-2030)

Figure 28. Germany Tumor-Specific Antigen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. France Tumor-Specific Antigen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. U.K. Tumor-Specific Antigen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Italy Tumor-Specific Antigen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Russia Tumor-Specific Antigen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Nordic Countries Tumor-Specific Antigen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. China Tumor-Specific Antigen Market Size YoY (2019-2030) & (US$ Million)

Figure 35. China Tumor-Specific Antigen Market Share by Type (2019-2030)

Figure 36. China Tumor-Specific Antigen Market Share by Application (2019-2030)

Figure 37. Asia Tumor-Specific Antigen Market Size YoY (2019-2030) & (US$ Million)

Figure 38. Asia Tumor-Specific Antigen Market Share by Type (2019-2030)

Figure 39. Asia Tumor-Specific Antigen Market Share by Application (2019-2030)

Figure 40. Asia Tumor-Specific Antigen Market Share by Region (2019-2030)

Figure 41. Japan Tumor-Specific Antigen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. South Korea Tumor-Specific Antigen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. China Taiwan Tumor-Specific Antigen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Southeast Asia Tumor-Specific Antigen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. India Tumor-Specific Antigen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Australia Tumor-Specific Antigen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Tumor-Specific Antigen Market Size YoY (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Tumor-Specific Antigen Market Share by Type (2019-2030)

Figure 49. Middle East, Africa, and Latin America Tumor-Specific Antigen Market Share by Application (2019-2030)

Figure 50. Middle East, Africa, and Latin America Tumor-Specific Antigen Market Share by Country (2019-2030)

Figure 51. Brazil Tumor-Specific Antigen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Mexico Tumor-Specific Antigen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Turkey Tumor-Specific Antigen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia Tumor-Specific Antigen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Israel Tumor-Specific Antigen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. GCC Countries Tumor-Specific Antigen Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Agilent Technologies Revenue Growth Rate in Tumor-Specific Antigen Business (2019-2024)

Figure 58. Creative Diagnostics Revenue Growth Rate in Tumor-Specific Antigen Business (2019-2024)

Figure 59. Go Therapeutics Revenue Growth Rate in Tumor-Specific Antigen Business (2019-2024)

Figure 60. Lee Biosolutions Revenue Growth Rate in Tumor-Specific Antigen Business (2019-2024)

Figure 61. Bio-Rad Revenue Growth Rate in Tumor-Specific Antigen Business (2019-2024)

Figure 62. Biomrieux Revenue Growth Rate in Tumor-Specific Antigen Business (2019-2024)

Figure 63. Caris Life Sciences Revenue Growth Rate in Tumor-Specific Antigen Business (2019-2024)

Figure 64. Roche Revenue Growth Rate in Tumor-Specific Antigen Business (2019-2024)

Figure 65. Abcam Revenue Growth Rate in Tumor-Specific Antigen Business (2019-2024)

Figure 66. Merck Group Revenue Growth Rate in Tumor-Specific Antigen Business (2019-2024)

Figure 67. PerkinElmer Revenue Growth Rate in Tumor-Specific Antigen Business (2019-2024)

Figure 68. OriGene Technologies Revenue Growth Rate in Tumor-Specific Antigen Business (2019-2024)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Tumor Targeting Peptides Market Research Report 2024

Global CD Antigen Cancer Therapy Market Research Report 2025

Global Solid Tumor Cancer Treatment Market Insights Forecast to 2030

Global Cell Separation and Characterization in Solid Tumors Market Insights Forecast to 2030

Global Solid Tumors Target Proteins Market Research Report 2024

Global Neoantigen Targeted Therapies Market Insights Forecast to 2030

Global Tumor Marker Testing Market Research Report 2024

Global Carbohydrate Antigen 19 9 Market Insights Forecast to 2030

Global Prostate Specific Antigen Market Research Report 2024

Global Prostate Specific Antigen PSA Biomarker Market Insights Forecast to 2030

Global mRNA Cancer Vaccines and Therapeutics Market Insights Forecast to 2030

Global Targeted Antitumor Drugs Market Research Report 2025

Global Tumor Tracking System Market Insights Forecast to 2030

Cancer Cell Analysis Market

Global Cellular Tumor Antigen p53 Market Research Report 2025

Global Tumor Immunity Therapy Market Research Report 2024

Peptide Cancer Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Solid Tumor Therapeutics Market Research Report 2024

Global Cancer Tumor Profiling Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions